Table 2.
Knowledge.
| Correctness rate N (%) | |
|---|---|
| K1: Major depressive disorder is the most common psychiatric disorder, with depression being its shorthand. | 46 (7.28) |
| K2: Clinical manifestations of depression are diverse, encompassing emotional, physical, and cognitive dimensions. | 523 (82.75) |
| K3: Difficulties in concentration, memory impairment, and decreased information processing speed may all manifest in individuals with depression as cognitive symptoms. | 536 (84.81) |
| K4: Cognitive symptoms in depression typically arise only during acute episodes. | 185 (29.27) |
| K5: Physical symptoms during depressive episodes can involve various organ systems, commonly presenting as early awakening, reduced appetite, and weight loss. | 551 (81.49) |
| K6: Comorbid anxiety disorders often accompany depression in patients, necessitating careful differentiation in clinical practice. | 547 (86.55) |
| K7: In the treatment of depression, the ultimate goal is the restoration of a patient’s social functioning and quality of life. | 467 (73.89) |
| K8: In clinical practice, it is essential to discern whether depression in a patient is a secondary condition caused by substances or medications. | 515 (81.49) |
| K9: The diagnosis of depression in patients should encompass a comprehensive assessment, including a medical history evaluation, psychiatric examination, assessment using relevant scales, neuroimaging for structural, functional, and metabolic changes, and so forth. | 534 (84.49) |
| K10: Combination therapy with antidepressant medication is the preferred approach for the treatment of depression, regardless of disease severity, with monotherapy not being considered. | 178 (28.16) |
| K11: A comprehensive assessment of cognitive functioning in individuals with depression requires both subjective and objective cognitive measurements or the use of comprehensive test tools. | 552 (87.34) |
| K12: Common guidelines for depression can be referenced, such as those provided by NICE, APA, WFSPB, among others. | 476 (75.32) |
| K13: The treatment of depression should adhere to a personalized medication approach, tailored to the individual patient’s circumstances. | 557 (88.13) |
| K14: Commonly used medications for the treatment of depression include tricyclic antidepressants and selective serotonin reuptake inhibitors, among others. | 471 (74.53) |
| K15: Antidepressant medications should ideally be used as monotherapy, with combination therapy considered only in cases of treatment-resistant depression to enhance efficacy. | 532 (84.18) |